ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Ueno on Liquid Biopsy

Naoto Tada Ueno, MD, PhD, FACP
Published: Monday, Dec 22, 2014

Naoto Tada Ueno, MD, PhD, FACP, from The University of Texas MD Anderson Cancer Center, discusses the advantages of liquid biopsy to detect and monitor tumor growth. 

It is difficult to subject patients to multiple traditional biopsies due to the potential risks and burden of the patient, explains Ueno.

Liquid biopsies, which use circulating tumor cells (CTCs) and fragments of tumor DNA, provide a bigger picture of biological changes at the metastatic site, without using invasive techniques.

Naoto Tada Ueno, MD, PhD, FACP, from The University of Texas MD Anderson Cancer Center, discusses the advantages of liquid biopsy to detect and monitor tumor growth. 

It is difficult to subject patients to multiple traditional biopsies due to the potential risks and burden of the patient, explains Ueno.

Liquid biopsies, which use circulating tumor cells (CTCs) and fragments of tumor DNA, provide a bigger picture of biological changes at the metastatic site, without using invasive techniques.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x